Estabrook Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$7.39K | – | 337 |
|
|
2024
Q4 | $7.39K | Hold |
10,000
| – | – | ﹤0.01% | 284 |
|
|
2024
Q3 | $15.7K | Hold |
10,000
| – | – | ﹤0.01% | 255 |
|
|
2024
Q2 | $16.8K | Hold |
10,000
| – | – | ﹤0.01% | 248 |
|
|
2024
Q1 | $24K | Hold |
10,000
| – | – | ﹤0.01% | 241 |
|
|
2023
Q4 | $15.3K | Hold |
10,000
| – | – | ﹤0.01% | 261 |
|
|
2023
Q3 | $10.9K | Hold |
10,000
| – | – | ﹤0.01% | 278 |
|
|
2023
Q2 | $22.9K | Hold |
10,000
| – | – | ﹤0.01% | 252 |
|
|
2023
Q1 | $24.3K | Hold |
10,000
| – | – | ﹤0.01% | 256 |
|
|
2022
Q4 | $19.1K | Hold |
10,000
| – | – | ﹤0.01% | 271 |
|
|
2022
Q3 | $24K | Hold |
10,000
| – | – | ﹤0.01% | 252 |
|
|
2022
Q2 | $18.6K | Hold |
10,000
| – | – | ﹤0.01% | 283 |
|
|
2022
Q1 | $20.9K | Hold |
10,000
| – | – | ﹤0.01% | 276 |
|
|
2021
Q4 | $39.4K | Buy |
+10,000
| New | +$39.4K | 0.01% | 246 |
|